|
GlaxoSmithKline Sees Promise in New Drug for Severe Asthma
Fox Business The injectable antibody treatment mepolizumab is designed to help a small group of people with asthma in which white blood cells called eosinophils cause inflammation of lung airways. It reduces the number of eosinophils by inhibiting an immune system … |
View full post on asthma – Google News